Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1 | American Journal of Physiology-Cell Physiology
High‐throughput RNA sequencing reveals structural differences of orthologous brain‐expressed genes between western lowland gorillas and humans - Lipovich - 2016 - Journal of Comparative Neurology - Wiley Online Library
IJMS | Free Full-Text | SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and Disease
Association between Pro12Ala and His477His polymorphisms in PPARG gene and insulin resistance in patients with polycystic ovary syndrome - Biochemia Medica
Novel 5′ Exon of Scavenger Receptor CD36 Is Expressed in Cultured Human Vascular Smooth Muscle Cells and Atherosclerotic Plaques | Arteriosclerosis, Thrombosis, and Vascular Biology
The role of PPARγ in prostate cancer development and progression | British Journal of Cancer
Splice variants of metabolic nuclear receptors: Relevance for metabolic disease and therapeutic targeting - ScienceDirect
IJMS | Free Full-Text | Alternative mRNA Splicing in the Pathogenesis of Obesity
Pax-8–PPAR-γ fusion protein in thyroid carcinoma | Nature Reviews Endocrinology
Antagonistic functions of LMNA isoforms in energy expenditure and lifespan | EMBO reports
IJMS | Free Full-Text | TRα2—An Untuned Second Fiddle or Fine-Tuning Thyroid Hormone Action?
Calculo y Selección de Fajas | PDF | Transmisión (Mecánica) | Science
ZERO... - Mark Herman, Harris County Constable Precinct 4 | Facebook
PDF) Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes | M. Caramori - Academia.edu
IJMS | Free Full-Text | SLU7: A New Hub of Gene Expression Regulation—From Epigenetics to Protein Stability in Health and Disease
Frontiers | A Novel Dnmt3a1 Transcript Inhibits Adipogenesis
DPY19L2 novel point mutations. (a) Electropherogram of DPY19L2 exon 8,... | Download Scientific Diagram
Peroxisome proliferator-activated receptors as molecular targets in relation to obesity and Type 2 diabetes | Pharmacogenomics